Literature DB >> 16794118

New recommendation for N-acetylcystiene dosing may reduce incidence of adverse effects.

R Duncan, G Cantlay, B Paterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16794118      PMCID： PMC2579567          DOI： 10.1136/emj.2005.031104

Source DB:  PubMed          Journal:  Emerg Med J        ISSN： 1472-0205            Impact factor:   2.740


× No keyword cloud information.
  3 in total

1.  Anaphylactoid response to intravenous acetylcysteine.

Authors:  W Sunman; A D Hughes; P S Sever
Journal:  Lancet       Date:  1992-05-16       Impact factor: 79.321

Review 2.  Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.

Authors:  C L Sheen; J F Dillon; D N Bateman; K J Simpson; T M Macdonald
Journal:  QJM       Date:  2002-09

Review 3.  Use of N-acetylcysteine in clinical toxicology.

Authors:  R J Flanagan; T J Meredith
Journal:  Am J Med       Date:  1991-09-30       Impact factor: 4.965
  3 in total
  2 in total

Review 1.  A Review of the Toxicologic Implications of Obesity.

Authors:  Matthew Zuckerman; Howard A Greller; Kavita M Babu
Journal:  J Med Toxicol       Date:  2015-09

2.  Fatal myocardial infarction associated with intravenous N-acetylcysteine error.

Authors:  Andrew R Elms; Kelly P Owen; Timothy E Albertson; Mark E Sutter
Journal:  Int J Emerg Med       Date:  2011-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.